Current treatment techniques for brain metastases

15th January 2021  13:00 - 16:30 (GMT+00:00) GMT

Virtual event – Friday 15 January 13:00-16:30 GMT
3 CPD points

This event is going virtual! All delegates currently booked on this event have been transferred to the new date and informed by email.

This half-day virtual event will bring together leaders in the treatment of brain metastases and will inform best practice and provide practical approaches to overcoming clinical challenges. This afternoon will create a forum where specialists can educate and inform on their practice and techniques whilst gaining a fresh insight into the solutions of others. Novel research and development ideas will be discussed at this meeting.

There will be opportunities for networking and collaboration amongst experts. The latest solutions from industry leaders will also be available to delegates, helping them to remain informed on the latest technological advances. A debate around the question “Is SRS always the preferred treatment option over whole brain radiotherapy?” will provide an opportunity for delegate participation with the polling of opinion before and after the debate.

View the virtual programme here

Educational aims:

  • To inform on best practice from leaders in the treatment of brain metastases
  • To create opportunities for discussion with leading experts
  • To provide an interactive debate on the question “Is SRS always the preferred treatment option over whole brain radiotherapy?”

The session will be recorded if you are unable to attend on the day and will be available on-demand to those who have registered.

Further updates

Follow us on Twitter @BIR_News or sign up for our email alerts here to get further updates on our educational programmes

Become a member of the BIR to gain access to hundreds of other webinars and online learning tools for free today!

EARLY BIRD Registration fees:
Non members £65
Plan 1 members £45
Plan 2/Trainee members £35
Retired/student member £30
*EARLY BIRD rates expire on Friday 18 December 2020

Registration fees:
Non members £85
Plan 1 members £55
Plan 2 members £45
Trainee members £45
Retired/student member £35

*VAT will be added at checkout, where applicable


We would like to present the abstract submissions for this years’ event. Please take time to view these ePosters presentations from the submitters.

Payment for all events must be made via a debit or credit card. Invoices and PO numbers cannot be used for registration payment. If you need your hospital, Trust, or organisation to pay for registration fees please have them contact our events team at Please note VAT will be added for all virtual events to the registration fees listed. For any further inquiries please contact
If you are having issues registering for the event please create or login to your MyBIR account via this link and then register for the event after you have logged in. If you are still experiencing any issues please email




We are very grateful to the following organisations for supporting this event.

Advanced Accelerator Applications

Advanced Accelerator Applications, S.A. (AAA), a Novartis company, is an innovative medicines company developing targeted radioligand therapies and precision imaging radioligands for oncology. We are committed to transforming patients’ lives by leading innovation in nuclear medicine. AAA currently has over 1,000 employees working across 31 sites in 12 countries (Canada, France, Germany, Israel, Italy, the Netherlands, Poland, Portugal, Spain, Switzerland, the UK and the US). The company also has global manufacturing capabilities with 19 facilities in eight countries, and six research & development sites. For more information, please visit:

Bayer Healthcare

Bayer’s Radiology business is well placed to be the partner of choice in helping NHS trusts to address the many challenges faced today including the increasing need for governance to demonstrate best practice and improving patient care within increasing financial constraints. With market-leading contrast media and power injector systems, Bayer is able to offer innovative patient care and with the addition of its informatics platform, it can support radiology departments in driving protocol standardisation and easily accessible audit data that enable departments to meet further challenges faced around contrast and radiation dose management. 0118 2063999

Elekta Ltd

For almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to – and benefits from – more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit or follow @Elekta on Twitter, Facebook and LinkedIn.

GE Healthcare Ltd

GE Healthcare is a leading provider of medical imaging, monitoring, and life science technologies. GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services to help providers, researchers and life sciences companies in their mission to improve outcomes for patients around the world.

Philips Healthcare

Enabling better health and better care at lower cost Philips is a leading health technology company focused on improving people`s lives across the health continuum - from healthy living and prevention, to diagnosis, treatment and home care. Applying advanced technologies and deep clinical and consumer insights, Philips delivers integrated solutions that improve people`s health and enable better outcomes. Partnering with its customers, Philips seeks to transform how healthcare is delivered and experienced. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care.


PTW designs and manufactures dosimetry and quality control equipment for use in the medical field, especially in radiation therapy. We have a global network of subsidiaries, including here in the UK and ROI. Our products are known throughout the world and are recognized for their workmanship and high quality.

Siemens Healthineers

At Siemens Healthineers, our mission is to enable healthcare providers to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, and improving patient experience, all enabled by digitalising healthcare. An estimated five million patients worldwide everyday benefit from our innovative technologies and services in the areas of diagnostic and therapeutic imaging, laboratory diagnostics and molecular medicine as well as digital health and enterprise services. We're a leading medical technology company with over 120 years of experience and 18,500 patents globally. With over 50,000 employees in more than 70 countries, we'll continue to innovate and shape the future of healthcare. For more information and latest product line, please visit

Varian Medical Systems UK Ltd

Varian is dedicated to connecting all care to realize a world without fear of cancer. And we’ll achieve that goal through Intelligent Cancer Care. We’re resolutely facing today’s unique challenges by connecting us all through more personalized treatment, more data-driven decision-making, more direct access to care, and a new, more unifying, smarter standard of oncology